|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print November 5, 2002
Am J Physiol Endocrinol Metab, 10.1152/ajpendo.00319.2002
Submitted on July 16, 2002
Accepted on October 29, 2002
1 Department of Geriatric Medicine and Metabolic Diseases, II University of Naples, Napoli, Italy
2 Geriatric Department, Italian National Research Center on Aging, Laboratory of Clinical Epidemiology, Florence, Italy
3 Department of Experimental Pathology, University of Bologna, Bologna, Italy
4 Molecolar Biology Section, Italian National Research Center on Aging, Ancona, Italy
5 Epidemiology, Demography and Biometry Laboratory, National Institute of Aging, Bethesda, USA
* To whom correspondence should be addressed. E-mail: giuseppe.paolisso{at}unina2.it.
Deregulation of the inflammatory response, plays a major role in the age-related decline of physical performance. The causal pathway leading from inflammation to disability has not been fully clarified, but several researches suggest that Interleukin-6 causes a reduction of physical performance in elderly through its effect on muscle function. In vitro studies demonstrated that Interleukin-6 inhibits the secretion of IGF-1 and its biological activity suggesting that the negative effect of Interleukin-6 on muscle function might be mediated through IGF-1. We evaluated the joint effect of IGF-1 and Interleukin-6 on muscle function in a population based sample of 526 persons with a wide age range (20-102 years). After adjusting for potential confounders, such as age, sex, body mass index, IL-6 receptor and IL-6 promoter polymorphism, Interleukin-6, IGF-1, and their interaction were significant predictors of handgrip and muscle power. In analyses stratified by Interleukin-6 tertiles, IGF-1 was an independent predictor of muscle function only in subjects in the lowest Interleukin-6 tertile suggesting that the effect of IGF-1 on muscle function depends on Interleukin-6 levels. This mechanism may explain why Interleukin-6 is a strong risk factor for disability.
This article has been cited by other articles:
![]() |
B. Cankaya, B. P. Chapman, N. L. Talbot, J. Moynihan, and P. R. Duberstein History of Sudden Unexpected Loss Is Associated With Elevated Interleukin-6 and Decreased Insulin-Like Growth Factor-1 in Women in an Urban Primary Care Setting Psychosom Med, November 1, 2009; 71(9): 914 - 919. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.L. Szanton, J.K. Allen, C.L. Seplaki, K. Bandeen-Roche, and L.P. Fried Allostatic Load and Frailty in the Women's Health and Aging Studies Biol Res Nurs, January 1, 2009; 10(3): 248 - 256. [Abstract] [PDF] |
||||
![]() |
K. A. Huey and B. M. Meador Contribution of IL-6 to the Hsp72, Hsp25, and {alpha}{beta}-crystallin responses to inflammation and exercise training in mouse skeletal and cardiac muscle J Appl Physiol, December 1, 2008; 105(6): 1830 - 1836. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Marzani, M. Balage, A. Venien, T. Astruc, I. Papet, D. Dardevet, and L. Mosoni Antioxidant Supplementation Restores Defective Leucine Stimulation of Protein Synthesis in Skeletal Muscle from Old Rats J. Nutr., November 1, 2008; 138(11): 2205 - 2211. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Meador, C. P. Krzyszton, R. W. Johnson, and K. A. Huey Effects of IL-10 and age on IL-6, IL-1{beta}, and TNF-{alpha} responses in mouse skeletal and cardiac muscle to an acute inflammatory insult J Appl Physiol, April 1, 2008; 104(4): 991 - 997. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Nemet, A. Eliakim, F. Zaldivar, and D. M. Cooper Effect of rhIL-6 infusion on GH->IGF-I axis mediators in humans Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1663 - R1668. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Onder, R. Liperoti, A. Russo, M. Soldato, E. Capoluongo, S. Volpato, M. Cesari, F. Ameglio, R. Bernabei, and F. Landi Body mass index, free insulin-like growth factor I, and physical function among older adults: results from the ilSIRENTE study Am J Physiol Endocrinol Metab, October 1, 2006; 291(4): E829 - E834. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Maggio, J. M. Guralnik, D. L. Longo, and L. Ferrucci Interleukin-6 in aging and chronic disease: a magnificent pathway. J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2006; 61(6): 575 - 584. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zaldivar, J. Wang-Rodriguez, D. Nemet, C. Schwindt, P. Galassetti, P. J. Mills, L. D. Wilson, and D. M. Cooper Constitutive pro- and anti-inflammatory cytokine and growth factor response to exercise in leukocytes J Appl Physiol, April 1, 2006; 100(4): 1124 - 1133. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Geroldi, G. B. Frisoni, G. Paolisso, S. Bandinelli, M. Lamponi, A. M. Abbatecola, O. Zanetti, J. M. Guralnik, and L. Ferrucci Insulin Resistance in Cognitive Impairment: The InCHIANTI Study Arch Neurol, July 1, 2005; 62(7): 1067 - 1072. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Haddad, F. Zaldivar, D. M. Cooper, and G. R. Adams IL-6-induced skeletal muscle atrophy J Appl Physiol, March 1, 2005; 98(3): 911 - 917. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Axelsson, A. Rashid Qureshi, M. E Suliman, H. Honda, R. Pecoits-Filho, O. Heimburger, B. Lindholm, T. Cederholm, and P. Stenvinkel Truncal fat mass as a contributor to inflammation in end-stage renal disease Am. J. Clinical Nutrition, November 1, 2004; 80(5): 1222 - 1229. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A Dennis, T. A Trappe, P. Simpson, C. Carroll, B. E. Huang, R. Nagarajan, E. Bearden, C. Gurley, G. W Duff, W. J Evans, et al. Interleukin-1 polymorphisms are associated with the inflammatory response in human muscle to acute resistance exercise J. Physiol., November 1, 2004; 560(3): 617 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Frost, G. J. Nystrom, and C. H. Lang Epinephrine stimulates IL-6 expression in skeletal muscle and C2C12 myoblasts: role of c-Jun NH2-terminal kinase and histone deacetylase activity Am J Physiol Endocrinol Metab, May 1, 2004; 286(5): E809 - E817. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Frost, G. J. Nystrom, and C. H. Lang Lipopolysaccharide and proinflammatory cytokines stimulate interleukin-6 expression in C2C12 myoblasts: role of the Jun NH2-terminal kinase Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2003; 285(5): R1153 - R1164. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |